Emmaus Life Sciences, Inc. Quarterly Current Federal Tax Expense (Benefit) in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Current Federal Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2024.
  • Emmaus Life Sciences, Inc. Current Federal Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Emmaus Life Sciences, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $30K, a 20% increase from 2021.
  • Emmaus Life Sciences, Inc. annual Current Federal Tax Expense (Benefit) for 2021 was $25K, a 45.7% decline from 2020.
  • Emmaus Life Sciences, Inc. annual Current Federal Tax Expense (Benefit) for 2020 was $46K, a 72% decline from 2019.
Current Federal Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-10
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-13
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2021-09-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.